Deferred Tax Assets, Net of Valuation Allowance of Co-Diagnostics, Inc. from 31 Dec 2019 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary: Co-Diagnostics, Inc. quarterly Deferred Tax Assets, Net of Valuation Allowance in USD history and change rate from 31 Dec 2019 to 31 Dec 2024.
Co-Diagnostics, Inc. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 31 Dec 2024 was $7,193,851, a 14% decline year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)

Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Change (%)

Co-Diagnostics, Inc. Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$7,193,851	-$1,133,219	-14%	31 Dec 2024	10-K	27 Mar 2025	2024	FY
Q4 2023	$8,327,070	+$3,182,855	+62%	31 Dec 2023	10-K	27 Mar 2025	2024	FY
Q4 2022	$5,144,215	-$2,084,229	-29%	31 Dec 2022	10-K	14 Mar 2024	2023	FY
Q4 2021	$7,228,444	+$6,681,220	+1221%	31 Dec 2021	10-K	24 Mar 2022	2021	FY
Q4 2020	$547,224	-$4,614,276	-89%	31 Dec 2020	10-K	24 Mar 2022	2021	FY
Q4 2019	$5,161,500			31 Dec 2019	10-K	25 Mar 2021	2020	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.